Ankara Bilkent City Hospital
Ankara, Turkey (Türkiye)
NCT Number: NCT07342894
This study aims to evaluate whether the timing of Hemovac drain removal affects early clinical outcomes after primary total knee arthroplasty (TKA). Hemovac drains are commonly used after TKA to reduce postoperative bleeding and swelling; however, the optimal timing for drain removal remains controversial.
In this prospective observational cohort study, patients undergoing primary TKA for knee osteoarthritis will be divided into two groups according to routine clinical practice: those whose drain is removed before the first postoperative rehabilitation session and those whose drain is removed after the first rehabilitation session.
The primary outcomes include the rate of postoperative hemarthrosis, early postoperative complications, and length of hospital stay. Secondary outcomes include postoperative pain levels and functional outcomes. The results of this study may help optimize postoperative management strategies following total knee arthroplasty.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Ankara, Turkey (Türkiye)
Total knee arthroplasty (TKA) is a widely performed surgical procedure for the treatment of advanced knee osteoarthritis. Postoperative management often includes the use of closed suction drains, such as Hemovac systems, to reduce hematoma formation and wound complications. However, the necessity and optimal timing of drain removal remain subjects of debate.
This prospective observational cohort study is designed to compare early clinical outcomes associated with two different timings of Hemovac drain removal following primary TKA. Patients who undergo primary TKA at a single tertiary care center will be enrolled prospectively. According to routine postoperative practice, patients will be allocated into two groups: drain removal before the first postoperative rehabilitation session or drain removal after completion of the first rehabilitation session.
All patients will receive standardized surgical techniques, anesthesia protocols, postoperative care, and rehabilitation programs. Data will be collected prospectively. Primary outcomes include postoperative hemarthrosis, early postoperative complications, and length of hospital stay. Secondary outcomes include postoperative pain intensity and functional outcome measures.
This study aims to provide evidence to guide clinical decision-making regarding postoperative drain management in patients undergoing total knee arthroplasty.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Postoperative days 0-3
Total postoperative Hemovac drain output measured in milliliters following primary total knee arthroplasty.
Time frame: Postoperative days 0-discharge
Duration of postoperative hospital stay measured in days.
Time frame: Postoperative first 24-48 hours
Change in hemoglobin level from preoperative baseline to postoperative measurement.
Time frame: Postoperative 1 month
Functional outcome assessed using the Knee Society Score.
Time frame: Postoperative 1 month
Pain intensity assessed using the Visual Analog Scale (VAS).
Ankara City Hospital Bilkent
Other
Effect of Timing of Hemovac Drain Removal on Early Outcomes After Total Knee Arthroplasty
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07705971
Arthritis, Joint Diseases
Denizli, Turkey (Türkiye)
View Trial DetailsNCT07494708
Arthritis, Hemorrhage
Islamabad, Fedral, Pakistan
View Trial DetailsNCT07320833
Arthritis, Bites and Stings
Cairo, Cairo Governorate, Egypt
View Trial DetailsNCT07134283
Arthritis, Cryotherapy
Ankara, Turkey (Türkiye)
View Trial Details